|
| Press Releases |
|
 |
|
| Friday, June 13, 2025 |
|
|
Jacobson Pharma Announces FY2025 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing, and sale of essential medicines and specialty drugs, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2025 ("FY2025" or the "Reporting Period"). more info >> |
|
| Friday, November 22, 2024 |
|
|
Jacobson Pharma Announces FY2025 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines and specialty drugs, today announced the interim results of the Company and its subsidiaries (collectively, the "Group") for the six months ended 30 September 2024 (the "Reporting Period"). more info >> |
|
| Friday, November 25, 2022 |
|
|
Jacobson Pharma Announces FY2023 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
| Wednesday, June 29, 2022 |
|
|
Jacobson Pharma Announces FY2022 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period"). more info >> |
|
| Wednesday, June 15, 2022 |
|
|
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia |
| Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group) more info >> |
|
| Monday, March 14, 2022 |
|
|
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60% |
| Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the "Company"; together with its subsidiaries, the "Group"; Stock Code: 2633), a leading company engaged in the research more info >> |
|
| Friday, November 26, 2021 |
|
|
Jacobson Pharma Announces FY2022 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines more info >> |
|
| Tuesday, June 29, 2021 |
|
|
Jacobson Pharma Announces FY2021 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products more info >> |
|
| Friday, February 5, 2021 |
|
|
JBM (Healthcare) Limited Debuts on The Main Board of SEHK |
| JBM (Healthcare) Limited ("JBM Healthcare" or "Company", together with its subsidiaries, the "Group"), a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries, started trading today on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") under stock code 2161. more info >> |
|
| Monday, January 25, 2021 |
|
|
JBM (Healthcare) Limited to Be Spun Off from Jacobson Pharma Corporation Limited |
| JBM (Healthcare) Limited ("JBM Healthcare" or "Company" and, together with its subsidiaries, the "Group"), a Hong Kong-based company that markets and distributes branded healthcare products with product footprint across Greater China, Southeast Asia and certain other countries, today announced details of the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK"). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Patriot Critical Minerals Announces Corporate Update Regarding NI 43-101 Technical Report
Jan 8, 2026 09:00 HKT/SGT
|
|
|
Unearthing experimental data buried in scientific papers 
Jan 8, 2026 00:00 HKT/SGT
|
|
|
RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion
Jan 7, 2026 22:30 HKT/SGT
|
|
|
TOYOTA GAZOO Racing Reverting to "GAZOO Racing" to Pass on and Evolve the Making of Ever-better Cars and the Fostering of Talent
Jan 7, 2026 22:04 JST
|
|
|
TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Release "The TANAKA 2025" a Perfume that Expresses the Fragrance of Gold (Au)
Jan 7, 2026 22:00 JST
|
|
|
Toyota's European R&D center changes its name and competes in WEC with a new brand
Jan 7, 2026 21:50 JST
|
|
|
Military Metals Drills 23.2 Meters of 2.22% Antimony Including 7.9 Meters of 4.9% Antimony and 23.2 Meters of 1.27 g/t Gold Including 6.2 Meters of 3.17 g/t Gold at Flagship Trojarova Project
Jan 7, 2026 20:45 HKT/SGT
|
|
|
Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries
Jan 7, 2026 12:27 JST
|
|
|
Fullerton Health Deepens Specialty Care Capabilities Through Acquisition of Singapore-Based Otolaryngology Practice, The ENT Clinic
Jan 7, 2026 10:30 HKT/SGT
|
|
|
Radisson Announces Additional High-Grade Drill Results and Further Extends New Mineralization Beneath the Historic O'Brien Gold Mine
Jan 6, 2026 20:00 HKT/SGT
|
|
|
Hong Kong Toys & Games Fair leads market innovation, debut 'Pop & Play' pavilion opens to industry and public
Jan 6, 2026 18:50 HKT/SGT
|
|
|
CTF Life Amplifies Ecosystem Synergy
Jan 6, 2026 15:35 HKT/SGT
|
|
|
Mitsubishi Motors to Celebrate "Delica Festival" with Custom Versions of Delica D:5 and Delica Mini at Tokyo Auto Salon 2026
Jan 6, 2026 16:25 JST
|
|
|
Mitsubishi Motors Launches the Xforce in Taiwan
Jan 6, 2026 14:42 JST
|
|
|
">
Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China
Jan 6, 2026 10:43 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
